NO
Healthcare & Life Sciences
NovImmune
Switzerland
NovImmune is a Healthcare & Life Sciences startup based in Switzerland, most recent round Series C+, 3 tracked investors.
series-c-plus
series-c-plus
Stage
3
Investors
About NovImmune
NovImmune is a company headquartered in Switzerland. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
NovImmune develops innovative therapies focused on the modulation of the immune system to treat inflammatory and autoimmune diseases.
Explore NovImmune's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.